Showing results (151-160 of 182) with videos related to
Sort By:
Pageof 19
International Journal of Molecular Sciences|July 9, 2022
The Role of Polymorphisms at the Interleukin-1, Interleukin-4, GATA-3 and Cyclooxygenase-2 Genes in Non-Surgical Periodontal TherapyKay-Arne Walther, José Roberto Gonzales, Sabine Gröger, et al.Journal of Clinical Periodontology|October 28, 2022
Development and international validation of logistic regression and machine-learning models for the prediction of 10-year molar lossGiuseppe Troiano, Luigi Nibali, Hari Petsos, et al.Journal of Clinical Periodontology|April 6, 2020
Effect of periodontal therapy on adipokine biomarkers in overweightJohannes Matern, Raphael Koch, Astrid Petersmann, et al.Genomics|August 30, 2008
Polymorphisms in the interleukin-1 (IL1) gene cluster are not associated with aggressive periodontitis in a large Caucasian populationAndreas Fiebig, Søren Jepsen, Bruno G Loos, et al.Journal of Clinical Periodontology|August 8, 2015
Is progression of periodontitis relevantly influenced by systemic antibiotics? A clinical randomized trialInga Harks, Raphael Koch, Peter Eickholz, et al.Plos One|April 19, 2018
Do we treat our patients or rather periodontal microbes with adjunctive antibiotics in periodontal therapy? A 16S rDNA microbial community analysisDaniel Hagenfeld, Raphael Koch, Sebastian Jünemann, et al.BMC Medical Genetics|August 11, 2010
Replication of the association of chromosomal region 9p21.3 with generalized aggressive periodontitis (gAgP) using an independent case-control cohortFlorian D Ernst, Katharina Uhr, Alexander Teumer, et al.Journal of Clinical Periodontology|May 10, 2023
Long-term changes in the subgingival microbiota in patients with stage III-IV periodontitis treated by mechanical therapy and adjunctive systemic antibiotics: A secondary analysis of a randomized controlled trialDaniel Hagenfeld, Sven Kleine Bardenhorst, Johannes Matern, et al.ERJ Open Research|July 19, 2023
A Phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: AirleafJames D Chalmers, Abhya Gupta, Sanjay H Chotirmall, et al.Microbiome|October 27, 2024
The role of the oral microbiota in the causal effect of adjunctive antibiotics on clinical outcomes in stage III-IV periodontitis patientsSven Kleine Bardenhorst, Daniel Hagenfeld, Johannes Matern, et al.Pageof 19